Craig Beavers opens by describing what worsening congestion looks like clinically—the hallmark presentations of shortness of breath and dyspnea, peripheral and ankle edema, hepatojugular reflex, and declining functional capacity and quality of life. He notes that gut edema can leave patients feeling full or unable to eat and that some patients appear dry externally while remaining congested internally, detectable through decreased renal function or elevated markers of hepatic congestion on lab workup. Beavers explains why oral furosemide fails precisely when patients need it most, calling the problem multifactorial: reduced renal function, impaired absorption from gut edema, and patients not understanding how to appropriately up-titrate their dose. Bypassing GI metabolization yields better bioavailability and greater delivery to the nephrons. He then defines the patient who needs more than an oral regimen but not admission—those returning post-hospitalization without expected weight loss or regaining weight and becoming symptomatic. He describes using a remote dielectric sensing device measuring thoracic impedance to assess fluid status and highlights patients facing social determinant barriers who cannot travel to a diuretic clinic. Catching this window early, he emphasizes, is critical to adequate diuresis and readmission prevention.